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Fibronectin is a major cell surface protein of normal fibroblasts (1-4) but is absent from 
the surface of transformed fibroblasts (2, 5-8). Fibronectin is also present in plasma (1, 9). 
It has  affinity to  fibrinogen  and  fibrin  and  is  identical  with  cold  insoluble  globulin 
(10-12). A recent comparison of fibronectins derived from human plasma and fibroblasts 
by analysis ofpolypeptide chains, peptide maps, and amino acid and carbohydrate compo- 
sitions, strongly suggests that they are the same protein (13). Fibronectin is present in 
the fibroblasts of different species as immunologically cross-reactive but  not  identical 
components  (14). Recent  results  from  our  laboratory  show  that  human  fibronectin, 
whether derived from cultured fibroblasts or plasma, binds to collagen (15). 
During  the  past  several years it  has become clear that  collagen exists  as  several 
distinct types determined by independent structural genes (16, 17). Type I collagen is the 
most prevalent form of collagen in the mature vertebrate organism and occurs in the 
arterial  walls,  bone,  dentin,  dermis,  tendon,  and  uterine  wall.  Type  II  is  almost 
exclusively limited to hyaline cartilages.  Type III collagen has a  distribution  pattern 
similar to that of type I, but is more prevalent in the distensible soft connective tissue. 
Recently,  additional  collagen  chains,  provisionally designated  as the  A  chain  and  B 
chain,  have  been  isolated  from extracts  of several  tissues  (18, 19), and  it  has  been 
suggested that molecules comprising these  chains may originate  in certain basement 
membrane structures. 
In view of the  possible importance of the  fibronectin-collagen  interaction  to 
the  structure  of the  ,rarious  connective  tissues,  we  decided  to investigate  the 
affinity of fibronectin  to the  various  genetic  types of collagen.  We  show  here 
that  all  types  of collagen  tested  are  active  in  fibronectin  binding,  but  to  a 
different degree.  Further,  we demonstrate that the collagen binding activity is 
shared  by fibronectins  of a  wide  variety of species.  We  also  present  evidence 
that  the  binding  to collagen  and  fibrinogen  is  mediated by the  same binding 
site in fibronectin. 
Materials  and  Methods 
Blood was collected in sodium citrate, and plasma was separated by centrifugation at room 
temperature.  Fresh plasma was used  for the purification,  or when  this was not possible,  the 
plasma was stored  frozen at -20°C.  Chicken  plasma was obtained from Pel-Freez  Farms, Inc., 
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(Rogers,  Ark.) and plasma from Torpedo californica  from Pacific Bio-Marine Laboratories,  Inc. 
(Venice, Calif.). 
Confluent cultures of chicken fibroblasts were kindly provided by Dr. J.  Strauss,  California 
Institute of Technology.  The cultures were washed three times with phosphate-buffered saline 
(PBS)  1 and extracted with 8  M  urea, 0.05 M Tris-HC1, pH 7.0, containing 10  -~ M phenylmethane- 
sulphonyl fluoride (PMSF).  Five roller bottles were extracted twice with a  total of 100 ml of the 
urea solution. The extracts were combined, centrifuged, and stored frozen.  Gelatin (swine skin, 
300  Bloom),  poly-L-proline  (mol  wt  10,000-30,000),  and cyanogen  bromide  activated Sepharose 
were from Sigma Chemical Co. (St. Louis, Mo.), and keratin from ICN, K & K Laboratories, Inc., 
(Plainview, N. Y.).  Pig tropoelastin was a gift from Dr. W. Gray, University of Utah, and a linear 
polymer  of the  tripeptide  pro-gly-pro  was  provided  by  Dr.  S.  Fuchs,  the  Weizmann  Institute 
(Rehovot, Israel).  Fibrinogen was obtained from Kabi AB (Stockholm, Sweden) and was purified 
further to remove contaminating fibronectin as described (10). 
Purification  of Fibronectin.  Plasma fibronectin was purified essentially as described earlier 
(15) using gelatin insolubilized on Sepharose. The modifications were that the plasma sample was 
passed  through  a  column  of plain  Sepharose  4B  before  fractionation on  gelatin-Sepharose  to 
remove material binding to  Sepharose.  The  amount of Sepharose  was twice the volume of the 
plasma sample. The gelatin-Sepharose column was washed with PBS containing 10 -4 PMSF and 
1 M  urea in 0.05 M Tris buffer, pH 7.5,  and the fibronectin was eluted with 4 M urea in 0.05 M 
Tris buffer.  Urea extracts of fibroblasts were diluted 20 times with PBS,  and  1 ml of gelatin- 
Sepharose was added per 200 ml of solution.  After incubation for 16 h  at 4°C,  the particles were 
packed in a column, washed,  and eluted as described above for plasma fibrenectin. 
Purification  of the Collagens.  Type  I  and III collagens were prepared from human placenta 
after  selubilization  by  limited  digestion  with  pepsin  and  fractionation  by  differential  salt 
precipitation at neutral pH as described previously (20). Briefly, these collagens were precipitated 
from the initial pepsin digest by adding NaC1 to a  concentration of 0.7  M.  The precipitate was 
collected, redissolved in 1.0 M  NaCl,  pH 7.5 (0.05  M Tris), and type III collagen was selectively 
precipitated  by  increasing  the  NaC1  concentration  to  1.5  M.  Type  I  collagen  was  similarly 
precipitated at 2.5 M NaC1. After the initial precipitation of type III and I collagens at 1.5 and 2.5 
M NaC1,  respectively, the precipitation from neutral salt solutions was repeated three times for 
each collagen. 
Collagen molecules comprising the A and B chains were isolated from the supernatant solution 
of the  original  pepsin  digest  after  precipitation  of the  type  I  and  III  collagens  (18).  For  this 
purpose,  the  NaCl  concentration was  raised  from  0.7  to  1.2  M.  The  resulting precipitate  was 
collected and redissolved in 1.0 M NaC1, pH 7.5 (0.05 M Tris). The collagen was then selectively 
precipitated from the latter solution at 4.5 M NaC1 (19).  The precipitation from the neutral salt 
solution was repeated three times. 
Type  II  collagen  was  prepared  from  infant  articular  cartilage.  This  collagen  was  likewise 
solubilized  by  limited  digestion  with  pepsin  and  purified  as  previously  described  (21).  The 
solubilized  collagen  was  precipitated  from  the  pepsin  digest  by  the  addition  of  NaC1  to  a 
concentration of 0.9 M.  The precipitate was redissolved in 1.0 M NaC1, pH 7.5 (0.05 M Tris), and 
the collagen was selectively precipitated from this solution by increasing the NaC1 concentration 
to 3.2 M. The latter precipitation was repeated three times. 
All of the collagens purified for the present study were ultimately redissolved in 0.5 M acetic 
acid, dialyzed extensively against the solvent, and lyophilized. 
The cyanogen bromide peptides,  al(II)-CB8 and al(II)-CB12, were isolated from the cleavage 
products of human al(II) chains as previously described (22). 
Before  testing,  collagens  and  peptides  were  dissolved  in  0.2%  acetic  acid.  Denaturation  of 
collagens was obtained by warming to 60°C for 30 min followed by rapid cooling in ice. 
Antisera.  Antisera were prepared against human and chicken plasma fibronectins. The latter 
were purified by the gelatin-Sepharose method described above. The antisera were adsorbed with 
Sepharose-conjugated  plasma proteins obtained from plasma passed through gelatin-Sepharose 
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(and devoid of fibronectin), bovine plasma proteins (including fibronectin) conjugated to Sepha- 
rose,  and  with  gelatin-Sepharose.  Antibodies to  fibronectin were  isolated  from  the  absorbed 
antisera by absorption to Sepharose-conjugated fibronectin followed by elution with 8 M urea. 
Assays for Fibronectin and Collagen Binding.  Quantitation of fibronectin was performed by 
radioimmunoassay  as  detailed  elsewhere  (23).  Tests  for binding  and  inhibition of binding of 
fibronectin to  various substances were  performed  using enzyme-linked immunosorbent assays 
(ELISA)  (15,  24)  performed  in polystyrene  microtiter plates  (ELISA plates,  Cooke  Laboratory 
Products Div., Dynatech Laboratories Inc., Alexandria, Va.). For binding assays, the wells were 
coated by incubation at room temperature with solutions containing 1 ~tg/ml of various proteins. 
Purified fibronectin was incubated in washed,  coated wells for 6 h.  After washing of the plato, 
bound fibronectin was quantitated by incubation overnight with excess enzyme-labeled, purified 
antibodies to fibronectin. 
For inhibition assays, the microtiter plate wells were coated with 0.5 pg/ml of gelatin. Human 
or  chicken  fibronectin,  0.5  /~g/ml,  with  or  without  various  concentrations  of  inhibitor  was 
incubated  in  the  wells,  and the  amount  of fibronectin bound to  the  wells  was  detected  with 
enzyme conjugated antibodies as described above. All incubations were performed at 4°C. Enzyme 
activities were measured at room temperature. 
Gel electrophoresis was performed in cylindrical  (25)  gels in the presence of sodium dodecyl 
sulphate (SDS).  Protein was determined according to Lowry et al.  (26). 
Results 
Purification  of Fibronectins.  We  have  previously  shown  that  fibronectin 
from  human  plasma  and  spent  culture  media  of human  fibroblasts  can  be 
isolated  on gelatin-Sepharose  (15).  Similar  binding  to  gelatin-Sepharose  was 
found  with  fibronectins  from  chicken  plasma  and  fibroblast  extracts.  Both 
preparations  showed  one  major  band  in  electrophoresis  (Fig.  1).  A  slight 
difference was repeatedly found in the  mobilities of the fibronectins from the 
two sources.  The  fibroblast fibronectin  was slightly  slower.  A  protein  with a 
mobility  similar  to  that  of mammalian  and  chicken  fibronectins  in  SDS gel 
electrophoresis was obtained from plasma of Torpedo fish (Torpedo californica). 
When run in SDS gel electrophoresis in the absence of reducing agent,  it also 
behaved like fibronectin,  giving a  band with an apparent  molecular weight of 
about  twice  the  size  of the  subunit.  The  yield  of this  protein,  tentatively 
identified  as  fibronectin,  was  comparable  to  that  obtained  with  mammalian 
fibronectins. 
Binding  of Fibronectin  to  Collagen, Fibrinogen,  and  Other  Proteins  and 
Glycoproteins.  Our  recent results  have  established  that  fibronectin exhibits 
an affinity for collagen and gelatin  (15).  The binding of fibronectin to collagen 
was further characterized using different types of human collagen.  It has also 
been  shown that  fibronectin  has  affinity to  fibrinogen  and  fibrin  (10).  Since 
fibrinogen  and  collagen  do not  have  much  in  common,  it  was  important  to 
compare  these  binding  activities  and  to  test  other  proteins  for  binding  of 
fibronectin. 
For  assays  of binding  of fibronectin,  microtiter  plates  were  coated  with 
various proteins.  All four preparations of collagen were found to bind fibronec- 
tin.  The denatured  forms of the collagens had a  higher binding capacity than 
the native collagens. Of the latter, type III collagen was the most efficient (Fig. 
2).  Fibrinogen  bound  much  less  fibronectin  than  the  collagens,  and  other 
proteins tested did not show significant  binding in this assay.  The binding of 
fibronectin  to fibrinogen  as well as to collagens was completely inhibited  by 
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FIG. I.  Gel  electrophoresis  in the  presence  of SDS  using cylindrical  gels with 5% 
polyacrylamide, a. Chicken plasma fibronectin  (left)  and chicken fibroblast  fibronectin 
(right).  Samples were reduced with 2% 2-mercaptoethanol. b. Fibronectin from Torpedo 
californica  plasma. The sample in  the left  gel  was run without  reduction,  and that  in  the 
right  gel  was reduced.  The positions  of  unreduced  IgG  (tool  wt 150,000)  and  reduced  human 
plasma fibronectin  (mol wt 220,000)  are shown. 
fibronectin to fibrinogen was inhibited by lower concentrations of gelatin than 
of fibrinogen itself (not shown). 
Lack  of Self-Aggregation  of Fibronectin.  We  have  noticed  that  purified 
fibronectin has a tendency to aggregate in concentrated solutions. Preparations 
of purified fibronectin eluted from the gelatin-Sepharose columns in concentra- 
tions of 1-3  mg/ml have olden formed a  gel-like precipitate upon freezing and 
storing,  even  in  the  presence  of 8  M  urea.  This  prompted  us  to  examine 
fibronectin for self-associating properties.  Fibronectin was coupled to  Sepha- 
rose, and the binding of 125I-labeled fibronectin to the particles was studied. The 
radioactivity bound to fibronectin-Sepharose was the same (6%) as binding to 
particles to which albumin was coupled, while gelatin-Sepharose bound more 
than 90% of the labeled protein. 
Avidity of  Binding of  Fibronectin to Collagens and Fibrinogen.  The binding 1588  AFFINITY  OF  FIBRONECTIN 
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FIG. 2.  Binding of fibronectin  to microtiter plate wells coated with different  proteins as 
detected  by enzyme labeled  antifibronectin.  Results  are  expressed  as relative  enzyme 
activities (%) compared to that obtained when the wells were coated with gelatin (100%). 
Hatched  bars, binding  to wells coated with native proteins,  solid bars, binding  to wells 
coated with heat denatured proteins, open bars, binding  in presence of 100/~g/ml gelatin. 
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FIG. 3.  Inhibition of binding of human fibronectin to microtiter plates coated with gelatin 
by collagen type I (IlL type II {A), type III (IlL and AB chains (©). Hatched lines,  native 
proteins.  Solid lines,  heat denatured proteins. 
of fibronectin to the different collagens was further characterized by testing the 
capacity  of the  collagens  to  inhibit  binding  of fibronectin  to  gelatin.  Of the 
native  collagens,  type  II!  was  the  most  efficient  inhibitor  (Fig.  3).  Heat 
denaturation  of the collagens abolished the differences between the  activity of 
type I, II, and III collagens, all of which became much more efficient inhibitors. 
Denaturation  had less effect on molecules composed of A  and B  chains,  which 
remained less active than denatured type I, II, and III collagens. 
Chicken fibronectin showed a  similar preference for denatured collagens and 
native type III collagen. A slight difference between the assay patterns obtained 
with  chicken  and  human  fibronectins  were  found,  but  chicken  fibronectins 
derived from plasma, and fibroblasts, respectively, showed identical specificities 
(Table I). 
Human  fibrinogen  had  some capacity to  inhibit  fibronectin-gelatin  interac- EVA  ENGVALL,  ERKKI  RUOSLAHTI,  AND  EDWARD  J.  MILLER 
TABLE I 
Inhibition of  Binding of Chicken Fibronectin,  Isolated from 
Plasma or Fibroblasts,  to Gelatin-Coated  Microtiter Plate Wells 
by Human Collagens 
pg/ml of collagen required for 50% 
inhibition of 
Plasma fibronec-  Fibroblast fibro- 
tin  nectin 
Native collagen type 
I  300  280 
II  > 100  > 100 
III  7.5  7.5 
AB  >200  >200 
Denatured collagen type 
I  1.5  1.7 
II  0.8  1.1 
III  1.3  1.6 
AB  130  150 
1589 
I00 
8O 
6O 
E 
"6  4O 
20 
0~0~0~ 
0 
;  ,;  ~;o  ~o'oo 
~g / ml 
FIG.  4.  Inhibition of binding of human  fibronectin to gelatin coated plates by fibrinogen 
(O), Torpedo californica fibronectin (O), and rabbit fibronectin (A). 
tion  at high  concentrations  (Fig.  4).  Serum albumin,  ovalbumin,  transferrin, 
and IgG did not inhibit when similarly tested. Fig. 4 also shows a comparison of 
the  gelatin-binding  activity  of Torpedo  fibronectin  with  rabbit  fibronectin. 
Torpedo fibronectin competed efficiently with human fibronectin for binding to 
gelatin  but was somewhat less active than  rabbit fibronectin.  The  latter  was 
used for comparison because rabbit antibodies to human fibronectin were used 
to detect the binding,  and such antibodies do not react with rabbit (or Torpedo) 
fibronectin (14,  27).  Torpedo fibronectin was also able to inhibit the binding of 
chicken  fibronectin  to  gelatin  and  was  in  this  assay  more  efficient  than  a 
preparation of bovine fibronectin (not shown). 
Localization  of Fibronectin  Binding  in  Collagen Polypeptide  Chains.  To 
study the question whether fibronectin binds to a single site or multiple sites on 1590  AFFINITY  OF  FIBRONECTIN  TO  COLLAQEN  AND  FIBRINOGEN 
~oo  ~  ~  ~--~ 
BO -  e~ 
~  ° 
.~  60  o  .\\. 
~  °~ 
20 -  °~O~o~o  A"~  A  ~  A 
o'.~  l  1o  ~oo  ~ooo 
~g  I  ml 
Fro.  5.  Inhibition of binding of human fibronectin to gelatin-coated microtiter plate wells 
by denatured type II collagen  (©) and two  cyanogen bromide fragments of al(II)  chains, 
CB8  (@),  and CB12  (A).  The synthetic polymer of pro-gly-pro  (A),  as well as polyproline 
(.),  do not inhibit. 
TABLE  II 
Binding of Fibronectin to Fibrin Clot in the Presence and Absence of Gelatin 
Sample  Temperature  Gelatin  Fibronectin 
~g/ml  % 
Exp.  1  Plasma  +4°C  -  270  100 
Serum  +4°C  -  10  4 
Serum  +4°C  2 mg/ml  110  40 
Serum  + 22°C  -  115  42 
Serum  +22°C  2 mg/ml  205  75 
Exp. 2  Plasma  +4°C  -  330  100 
Serum  +4°C  -  17  5 
Serum  +4°C  2 mg/ml  218  66 
Serum  + 37°C  -  172  52 
Serum  +37°C  2 mg/ml  135  41 
the  collagen  chains,  cyanogen  bromide  peptides  from  different  parts  of the 
al(II)  chain  were  analyzed  in  the  inhibition  assay.  Peptides  CB8  (13,000 
daltons)  and  CB12  (8,000  daltons)  were  both  able  to  inhibit  completely  the 
binding of fibronectin to gelatin  (Fig.  5).  Both peptides were more active than 
native type II collagen but less active than denatured type II collagen, which 
yields intact  al(II)  chains.  The smaller  of the two peptides,  CB12,  was more 
active than  the  larger,  CB8.  A  polymer of a  synthetic tripeptide  pro-gly-pro, 
which  has  a  secondary  structure  similar  to  collagen  and  has  been  shown  to 
elicit an immune response against collagen (28), did not inhibit the fibronectin- 
gelatin  interaction  in  concentrations  up  to  1  mg/ml.  Polyproline  was  also 
inactive. 
Effect of Gelatin on Incorporation of Fibronectin in Blood Clot.  Clotting of 
blood in the  cold results  in binding  of fibronectin  to the  fibrin  clot  (10).  The 
addition of gelatin to blood before coagulation partially prevented the incorpo- 
ration  of fibronectin into the blood clot  (Table II).  Gelatin  did not prevent or EVA  ENGVALL,  ERKKI  RUOSLAHTI,  AND  EDWARD  J.  MILLER  1591 
slow down coagulation,  but rather  encouraged it,  and  no fibrinogen  could be 
detected in serum from gelatin containing plasma as tested by immunodiffusion 
against antifibrinogen  serum. 
Discussion 
We have previously demonstrated  an affinity of the soluble form of human 
fibronectin  from  fibroblasts  and  plasma  for  collagen  and  gelatin  (15).  The 
present  results  extend  this  to  chicken  fibronectin.  A  protein  of Torpedo  fish 
plasma  with  molecular  properties  similar  to  the  mammalian  and  chicken 
fibronectins could also be isolated by utilizing the same affinity chromatography 
procedure that results in isolation of mammalian and chicken fibronectins. The 
fact  that  the  fish  protein  could be purified  on  gelatin-Sepharose  implies  an 
affinity  for  collagen.  Moreover,  the  fish  protein  competed  with  human  and 
chicken  fibronectins  for  binding  to  collagen  indicating  a  similar  specificity. 
Furthermore,  it  behaved similarly  to  fibronectin  in  SOS gel  electrophoresis. 
This evidence allows the tentative conclusion that this protein is a  homologue 
of the  mammalian  and chicken  fibronectins.  This,  and the fact that  we have 
been able to detect and isolate fibronectin from the plasma of every mammalian 
species studied (E. Engvall,  and E. Ruoslahti, unpublished results), shows that 
the affinity of fibronectin to collagen is shared by a  variety of species ranging 
from human to fish. 
Our results show that fibronectin is the only major component from plasma 
that binds to gelatin-Sepharose. It also is the only major component of fibroblast 
extracts  that  shows  this  property,  as  demonstrated  by  the  purification  of 
homogeneous  fibronectin  from  extracts  of chicken  fibroblasts.  These  results 
strongly suggest that the fibronectin-collagen interaction is not fortuitous, but, 
instead,  is likely to have biological significance. 
Since fibronectin  is a  cell surface component,  it is possible that  fibronectin 
could attach cells to the extracellular  matrix.  There is direct evidence from in 
vitro  experiments  that  this  is  the  case.  A  plasma  component  known  as  cell 
attachment  protein (CAP) and a  cell surface component called cell attachment 
factor (CAF) mediate the attachment  of cultured fibroblasts to collagen coated 
plates (29, 30). CAF and CAP are apparently identical to fibronectin (30, 31). To 
gain insight into what collagen-fibronectin interactions might occur in vivo, we 
analyzed the relative capacities of different genetic types of collagens and their 
unfolded derivatives to bind fibronectin.  It was found that  fibronectin showed 
preference  to  the  denatured  forms  of the  collagens.  A  similar  preference  is 
shown by some of the enzymes active in the post-translational  modifications of 
collagen, e.g., the glucosyl and galactosyl transferases as well as the prolyl and 
lysyl hydroxylases (32). It is unlikely that fibronectin would be identical to any 
of these enzymes, because they are  mainly intracellular  and present  in lower 
amounts than fibronectin. 
Limited information is available on the nature of the fibronectin binding site 
in collagen.  The fact that commercial gelatin preparations and heat-denatured 
collagens are active indicates that the binding site does not depend on an intact 
helical structure of collagen. 
We  have  also  found  that  two  peptides  representing  different  parts  of the 
al(II)  chain  are  both able to inhibit  completely the  binding of fibronectin to 1592  AFFINITY  OF  FIBRONECTIN  TO  COLLAGEN  AND  FIBRINOGEN 
gelatin.  The  CAP-mediated  attachment  of cells to  collagen-coated  plates  has 
also been shown  to  be inhibited  by several different cyanogen bromide frag- 
ments of the al(I),  a2, and al(II) chains (33). However, the specific peptides we 
have tested were not highly active in the cell attachment test. This is probably 
due  to  lower  sensitivity  of the  latter  test  as  compared  to  our  assay.  These 
results,  therefore, permit the tentative conclusion that the binding sites occur 
at  several  locations  in  the  collagen  sequence.  However,  it  has  been  shown 
earlier  (15)  that  free  proline,  hydroxyproline,  lysine,  glycine,  glucose,  and 
galactose  do  not  inhibit  the  fibronectin-collagen  interactions.  Moreover,  the 
present results indicate that the linear  polymers [proline-glycine-proline]  and 
pelyproline are also inactive. 
Immunofluorescence  shows  that  fibronectin  is  especially  abundant  in  the 
basement  membranes  (34).  It  was  somewhat  surprising  that  the  A  and  B 
chains, which are thought to be derived from certain basement membranes, are 
only moderately active in fibronectin binding.  Accordingly,  it will be of great 
interest to test other collagens derived from basement membranes for fibronec- 
tin  binding capacity.  Since the specialized functions of the different collagens 
are  not  completely  known,  it  is  difficult  to  assess  the  significance  of the 
differences in the activity of the different collagens in fibronectin binding. This 
may have little influence in vivo. Since all collagens are active to some extent, 
it  may  be  the  types  and  relative  amounts  of collagen  available  at  a  given 
location,  rather  than  the  relative  binding  activities,  that  determines  which 
collagen interacts with fibronectin. 
Fibronectin also binds to fibrinogen and fibrin (10, 12). Our results show that 
this binding was inhibited by gelatin,  and fibrinogen showed some inhibitory 
activity in an assay where fibronectin binds to gelatin.  When blood coagulates 
at  low  temperature,  fibronectin  binds  to  the  fibrin  clot  (10),  and  it  can  be 
covalently  linked  to  fibrin  by the  fibrin  stabilizing  factor  (11).  We  found  a 
marked reduction in the incorporation of fibronectin to the blood clot if gelatin 
was added to the blood before coagulation. These data strongly suggest that the 
same site on the fibronectin molecule is responsible for binding to collagen and 
fibrinogen,  but that the site has a  greater affinity for collagen sequences.  We 
cannot exclude the possibility that small amounts of collagen contaminate  the 
fibrinogen preparations we used.  However, it would be difficult to explain the 
binding  of fibronectin  to  the  fibrin  clots  by  assuming  that  the  affinity  of 
fibronectin for fibrinogen is actually due to binding to contaminating collagen. 
If fibronectin  in  tissues  serves  as  a  mediator  of attachment  of cells  to  the 
collagenous matrix,  the significance of the fibrinogen binding could be to allow 
temporary binding of the cells to a  fibrin scaffold in a  wound. 
Transformed  cells lack fibronectin of their  surface.  This  may contribute  to 
their capacity to grow uninhibitedly and metastasize, because they would lack 
the supportive, and possibly growth inhibitory,  attachment to the surrounding 
extracellular  matrix. 
Summary 
Fibronectin,  a  fibroblast  surface  protein,  was  purified  from  human  and 
chicken  plasma  and  extracts  of  cultured  chicken  fibroblasts  with  affinity EVA  ENGVALL,  ERKKI  RUOSLAHTI,  AND  EDWARD  J.  MILLER  1593 
chromatography on gelatin coupled to Sepharose particles.  A  fibronectin-like 
protein was also isolated from the plasma of Torpedo fish. 
The  collagen  binding  properties  of fibronectin  were  studied  with  several 
genetically distinct collagens. Heat denatured types I, II, and III collagens were 
equal in their binding capacity and more active than the native collagens or A 
and B chains.  Native type III collagen was more active than the other native 
collagens.  Human  and  chicken  fibronectins showed  approximately the  same 
pattern  of specificity.  Identical  specificities were  shown  by  the  plasma  and 
fibroblast forms of chicken fibronectin. Two cyanogen bromide peptides of the 
collagen al(II) chain, CB8 and CB12, derived from different parts of the chain, 
were active in fibronectin binding. A polymer of the tripeptide pro-gly-pro, and 
polyproline were inactive. 
Fibronectin also binds to fibrinogen and fibrin. Comparison of this binding to 
collagen  binding  showed  that  fibrinogen  inhibited  binding  of fibronectin to 
collagen, but was less active than native collagen. Two other fibrous proteins, 
tropoelastin and keratin, did not bind fibronectin. The binding of fibronectin to 
fibrinogen was inhibited by collagen and incorporation of fibronectin into blood 
clot in the cold was inhibited by gelatin. These results suggest that the binding 
of  fibronectin to collagen and fibrinogen depends on the same binding site in the 
fibronectin molecule. 
It is proposed that cell surface fibronectin mediates attachment of cells to the 
collagenous extracellular matrix and to a temporary fibrin matrix in a  wound. 
We thank  Aulikki Pekkala for technical assistance, Dr.  Sara Fuchs for a pro-gly-pro peptide 
sample, Dr. William Gray for elastin, and Dr. James Strauss for cultured fibroblasts. 
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